Wedbush Reaffirms Outperform Rating for Novadaq Technologies Inc. (NDQ)

Wedbush reaffirmed their outperform rating on shares of Novadaq Technologies Inc. (TSE:NDQ) in a research report released on Friday morning. They currently have a C$17.00 target price on the stock.

Separately, Royal Bank Of Canada reiterated an outperform rating on shares of Novadaq Technologies in a research note on Thursday, July 7th.

Novadaq Technologies (TSE:NDQ) opened at 12.96 on Friday. The firm’s market capitalization is $744.42 million. The company’s 50 day moving average price is $14.47 and its 200 day moving average price is $13.79. Novadaq Technologies has a 12 month low of $10.81 and a 12 month high of $20.40.

About Novadaq Technologies

Novadaq Technologies Inc is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed.

Receive News & Ratings for Novadaq Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novadaq Technologies Inc. and related companies with's FREE daily email newsletter.

Leave a Reply

© 2006-2016 Mideast Time.